Institut Pasteur, Unité des Agents Antibactériens, Paris Cedex 15, France.
J Biol Chem. 2012 Nov 2;287(45):37583-92. doi: 10.1074/jbc.M112.405522. Epub 2012 Sep 11.
d-Alanyl:d-lactate (d-Ala:d-Lac) and d-alanyl:d-serine ligases are key enzymes in vancomycin resistance of Gram-positive cocci. They catalyze a critical step in the synthesis of modified peptidoglycan precursors that are low binding affinity targets for vancomycin. The structure of the d-Ala:d-Lac ligase VanA led to the understanding of the molecular basis for its specificity, but that of d-Ala:d-Ser ligases had not been determined. We have investigated the enzymatic kinetics of the d-Ala:d-Ser ligase VanG from Enterococcus faecalis and solved its crystal structure in complex with ADP. The overall structure of VanG is similar to that of VanA but has significant differences mainly in the N-terminal and central domains. Based on reported mutagenesis data and comparison of the VanG and VanA structures, we show that residues Asp-243, Phe-252, and Arg-324 are molecular determinants for d-Ser selectivity. These residues are conserved in both enzymes and explain why VanA also displays d-Ala:d-Ser ligase activity, albeit with low catalytic efficiency in comparison with VanG. These observations suggest that d-Ala:d-Lac and d-Ala:d-Ser enzymes have evolved from a common ancestral d-Ala:d-X ligase. The crystal structure of VanG showed an unusual interaction between two dimers involving residues of the omega loop that are deeply anchored in the active site. We constructed an octapeptide mimicking the omega loop and found that it selectively inhibits VanG and VanA but not Staphylococcus aureus d-Ala:d-Ala ligase. This study provides additional insight into the molecular evolution of d-Ala:d-X ligases and could contribute to the development of new structure-based inhibitors of vancomycin resistance enzymes.
D-丙氨酰-D-乳酸(d-Ala:d-Lac)和 D-丙氨酰-D-丝氨酸连接酶是革兰氏阳性球菌万古霉素耐药性的关键酶。它们催化合成修饰的肽聚糖前体的关键步骤,这些前体是万古霉素的低亲和力靶标。VanA 型 D-Ala:d-Lac 连接酶的结构导致了对其特异性的分子基础的理解,但 D-Ala:d-Ser 连接酶的结构尚未确定。我们研究了来自粪肠球菌的 D-Ala:d-Ser 连接酶 VanG 的酶促动力学,并解决了其与 ADP 复合物的晶体结构。VanG 的整体结构与 VanA 相似,但主要在 N 端和中心结构域存在显著差异。基于报道的突变数据和 VanG 和 VanA 结构的比较,我们表明残基 Asp-243、Phe-252 和 Arg-324 是 d-Ser 选择性的分子决定因素。这些残基在两种酶中都保守,解释了为什么 VanA 也显示 D-Ala:d-Ser 连接酶活性,尽管与 VanG 相比,催化效率较低。这些观察结果表明,D-Ala:d-Lac 和 D-Ala:d-Ser 酶是从共同的祖先 D-Ala:d-X 连接酶进化而来的。VanG 的晶体结构显示了两个涉及ω环残基的二聚体之间的异常相互作用,这些残基深深地锚定在活性位点中。我们构建了一个八肽模拟ω环,发现它选择性地抑制 VanG 和 VanA,但不抑制金黄色葡萄球菌 D-Ala:d-Ala 连接酶。这项研究为 D-Ala:d-X 连接酶的分子进化提供了更多的见解,并可能有助于开发新的基于结构的万古霉素耐药酶抑制剂。